Shift in Beauty Industry: Clinical Efficacy Over Viral Trends
The beauty industry is witnessing a significant shift in consumer behavior. Shoppers are now prioritizing clinical efficacy and wellness-driven products over viral, trend-driven purchases, according to Consumer Edge’s Health and Beauty 2026 Outlook, published on May 27, 2026.
Despite a 14 percent drop in US direct-to-consumer beauty spending year-to-date, clinical and science-led brands such as Youth To The People, Rejuran, and Medik8 are outperforming the market. This is due to consumers demanding long-term value and measurable results, a major departure from the TikTok-driven impulse buying that dominated recent years.
Michael Gunther, SVP of Research and Market Intelligence at Consumer Edge, highlighted that beauty spending is fragmenting based on what consumers perceive as real value. He noted that the brands best positioned for success in the second half of 2026 are those:
- Reallocating investment toward products with clear, functional benefits
- Pressure-testing their growth assumptions against actual consumer spending patterns, particularly among younger demographics
The convergence of beauty and wellness continues to accelerate, with growing consumer interest in:
- Supplements
- Recovery tools
- At-home devices that deliver clinical-grade results
Industry analyst Larissa Jensen from Circana notes that fragrance, facial skincare, hair treatments, and personal care products like body lotion continue to benefit from consumers prioritizing self-care, elevated routines, and wellness-driven formulations.
The trend toward ‘smart beauty’ reflects a broader maturation of the market, where educated consumers seek products backed by science, transparent ingredient lists, and proven efficacy rather than just social media hype. This shift signals that the beauty industry must evolve beyond marketing aesthetics to deliver genuine health and wellness benefits.
